Intro -- Fourteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases -- 1. Opening of the meeting -- 2. Administrative matters, including revised terms of reference of STAG -- appointment of rapporteurs -- 3. Year in review -- 4. Director's report -- 4.1 Partnership and advocacy -- 4.2 Progress since the thirteenth meeting -- 4.3 NTDs and COVID-19 -- 4.4 Discussion -- 5. Progress reports from the Regions -- 5.1 Region of the Americas -- 5.2 Eastern Mediterranean Region -- 5.3 European Region -- 5.4 South-East Asia Region -- 5.5 Western Pacific Region -- 5.6 African Region -- 6. Road map companion documents -- 6.1 Sustainability framework -- 6.2 M& -- E framework -- 6.3 Global investment case -- 6.4 Global strategy on WASH and NTDs -- 6.5 One Health framework for action -- 7. Elimination dossiers: update and country experience -- 7.1 Update -- 7.2 Trachoma in Togo -- 7.3 Lymphatic filariasis in Bangladesh -- 8. Impact of COVID-19 -- 8.1 Impact on MDA and case-finding -- 8.2 Impact on MDA in 2020 -- 8.3 Impact on supply chain for NTD health products -- 9. Impact of FCDO funding cuts -- 9.1 On FCDO-supported NTD programmes globally: leishmaniasis (elimination and control) and dracunculiasis (eradication) -- 9.2 On ASCEND-supported countries in the African Region -- 10. Revision of criteria for NTDs -- 10.1 On including additional diseases into the portfolio of NTDs -- 10.3 Discussion -- 11. Integration of NTDs with malaria -- 12. Integration of NTDs with mental health -- 13. Forecasting of need for and access to NTD health products -- 14. Diagnostics -- 15. Partners' statements -- 16. STAG-NTD recommendations to the Director-General -- 17. Recommendation from the secretariat to STAG -- 18. Closure -- References -- Annex 1. Agenda -- Annex 2. List of participants.